ArticleScientific reports2025
Clinical and functional outcomes of masquelet technique for treating Fracture-related Infections(FRIs) in shoulder girdle.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Structural and functional integrity pose a challenge for the treatment of fracture-related infections (FRI) in the shoulder girdle. The purpose of this study was to assess the clinical and functional outcomes of patients treated with the Masquelet technique. From January 2012 to January 2023, sixty-two consecutive adult patients with FRI in the shoulder girdle (8 in clavicle and 54 in humerus) were treated using this technique. This involved the use of antibiotic bone cement to fill the dead space after debridement, followed by staged bone grafting. Patients' outcomes, in terms of infection resolution, bone union, and the Disabilities of the Arm, Shoulder, and Hand (DASH) score, were retrospectively analyzed. The follow-up time was at least 2 years. The mean age was 45.52±14.01 years. The initial fracture was open in 16 patients (25.8%) and closed in 46 patients (74.2%), Staphylococcus aureus (21.0%) was the most common pathogen. Thirty-six patients with large bone defects had additional locking plates for internal fixation. All patients achieved bone consolidation after a median follow-up of 24 months (range: 24-72 months) after the second stage bone graft. Clinical bone healing occurred at 4 months in 56.5%, at 6 months in 29.0%, and at 9 months in 14.5%. Seven patients required additional revision surgery. Three of these patients underwent repeated debridement before grafting due to incomplete infection control, while four had recurrence after the second-stage bone graft and required repeat surgery. The average DASH scores showed a significant decrease at the final follow-up, from a mean of 47.37 before surgery to a mean of 13.31. Following univariate analysis, patient age, post-debridement internal fixation, and bone graft type were not associated with the need for additional revision. However, patients aged ≥ 60 years (p = 0.004) and those with prolonged infection duration (p=0.002) were more likely to experience poor functional outcomes. The Masquelet technique, though requiring a staged approach, achieved reliable infection control and bony union in shoulder girdle FRIs, with favorable functional outcomes. This staged technique provided advantages through the use of antibiotic-loaded cement spacers, enabling local antibiotic treatment, dead space management, and post-debridement internal fixation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.